0.7629
price down icon3.43%   -0.0271
after-market アフターアワーズ: .76 -0.0029 -0.38%
loading
前日終値:
$0.79
開ける:
$0.787
24時間の取引高:
29,601
Relative Volume:
0.14
時価総額:
$1.62M
収益:
$4.70M
当期純損益:
$-4.99M
株価収益率:
-0.1188
EPS:
-6.42
ネットキャッシュフロー:
$-5.29M
1週間 パフォーマンス:
-0.99%
1か月 パフォーマンス:
+9.30%
6か月 パフォーマンス:
-46.65%
1年 パフォーマンス:
-79.34%
1日の値動き範囲:
Value
$0.7629
$0.787
1週間の範囲:
Value
$0.761
$0.8399
52週間の値動き範囲:
Value
$0.4519
$7.20

Salarius Pharmaceuticals Inc Stock (SLRX) Company Profile

Name
名前
Salarius Pharmaceuticals Inc
Name
セクター
Healthcare (1170)
Name
電話
346-772-0346
Name
住所
2450 HOLCOMBE BLVD, HOUSTON
Name
職員
2
Name
Twitter
@SalariusPharma
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
SLRX's Discussions on Twitter

SLRX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
SLRX
Salarius Pharmaceuticals Inc
0.7629 1.64M 4.70M -4.99M -5.29M -6.42
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Salarius Pharmaceuticals Inc Stock (SLRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2020-04-27 開始されました Ladenburg Thalmann Buy

Salarius Pharmaceuticals Inc (SLRX) 最新ニュース

pulisher
May 27, 2025

Liposarcoma Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 15+ Companies and 20+ Therapies | DelveInsight - GlobeNewswire Inc.

May 27, 2025
pulisher
May 15, 2025

Salarius: Q1 Earnings Snapshot - New Haven Register

May 15, 2025
pulisher
May 07, 2025

Salarius Pharmaceuticals (NASDAQ:SLRX) Trading Up 2.1% – Here’s Why - Defense World

May 07, 2025
pulisher
Apr 30, 2025

Financial Analysis: Hepion Pharmaceuticals (NASDAQ:HEPA) versus Salarius Pharmaceuticals (NASDAQ:SLRX) - Defense World

Apr 30, 2025
pulisher
Apr 27, 2025

Closing Figures Unveiled: Salarius Pharmaceuticals Inc (SLRX) Drop -26.34, Closes at 0.60 - DWinneX

Apr 27, 2025
pulisher
Apr 26, 2025

Salarius Pharmaceuticals faces Nasdaq delisting over rule breaches By Investing.com - Investing.com Canada

Apr 26, 2025
pulisher
Apr 25, 2025

Salarius Pharmaceuticals faces Nasdaq delisting over rule breaches - Investing.com

Apr 25, 2025
pulisher
Apr 16, 2025

Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Appoints Robert S. Langer To Scientific Advisory Board - citybiz

Apr 16, 2025
pulisher
Apr 16, 2025

Decoy Therapeutics to Welcome MIT's Robert Langer to Advisory Board Post-Merger with Salarius (SLRX) | SLRX Stock News - GuruFocus

Apr 16, 2025
pulisher
Apr 16, 2025

Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Appoints Renowned MIT Professor Robert S. Langer to its Scientific Advisory Board - The Manila Times

Apr 16, 2025
pulisher
Apr 16, 2025

Moderna Co-Founder and MIT Legend Strengthens Decoy Therapeutics Drug Development Team - Stock Titan

Apr 16, 2025
pulisher
Apr 15, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Apr 15, 2025
pulisher
Apr 09, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Apr 09, 2025
pulisher
Apr 02, 2025

SLRX stock touches 52-week low at $0.7 amid sharp annual decline - Investing.com Canada

Apr 02, 2025
pulisher
Apr 02, 2025

SLRX stock touches 52-week low at $0.7 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 02, 2025
pulisher
Apr 01, 2025

Contrasting Salarius Pharmaceuticals (NASDAQ:SLRX) & ASLAN Pharmaceuticals (NASDAQ:ASLN) - Defense World

Apr 01, 2025
pulisher
Mar 29, 2025

Salarius Amends Merger Terms, Faces Nasdaq Compliance Issue By Investing.com - Investing.com India

Mar 29, 2025
pulisher
Mar 28, 2025

Salarius Amends Merger Terms, Faces Nasdaq Compliance Issue - Investing.com

Mar 28, 2025
pulisher
Mar 27, 2025

Decoy Therapeutics’ antiviral candidates show broad activity against multiple viruses - BioWorld MedTech

Mar 27, 2025
pulisher
Mar 26, 2025

SLRX stock touches 52-week low at $0.83 amid market challenges By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

SLRX stock touches 52-week low at $0.83 amid market challenges - Investing.com Australia

Mar 26, 2025
pulisher
Mar 26, 2025

Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces Its Novel Inhibitors Show Promising In Silico Activity Against Measles And Related Viruses - MarketScreener

Mar 26, 2025
pulisher
Mar 26, 2025

Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces its Novel Inhibitors Show Promising In Silico Activity Against Measles and Related Viruses - GlobeNewswire

Mar 26, 2025
pulisher
Mar 26, 2025

Revolutionary AI Platform Discovers Multi-Target Antiviral in Just 5 Days - Stock Titan

Mar 26, 2025
pulisher
Mar 24, 2025

Salarius Pharmaceuticals Advances Merger with Decoy Therapeutics to Enhance Development of Innovative Cancer and Viral Therapeutics - Nasdaq

Mar 24, 2025
pulisher
Mar 24, 2025

Salarius Pharmaceuticals Reports 2024 Financial Results and Provides Business Update - GlobeNewswire

Mar 24, 2025
pulisher
Mar 21, 2025

Salarius Pharmaceuticals Inc. (SLRX) reports earnings - Quartz

Mar 21, 2025
pulisher
Mar 21, 2025

Salarius Pharmaceuticals, Inc. SEC 10-K Report - TradingView

Mar 21, 2025
pulisher
Mar 19, 2025

Apraxia Treatment Market Size in 7MM is expected to grow at - openPR.com

Mar 19, 2025
pulisher
Mar 13, 2025

Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) Short Interest Update - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

SLRX stock touches 52-week low at $0.9 amid market challenges - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

SLRX stock touches 52-week low at $0.9 amid market challenges By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 11, 2025

Salarius Pharmaceuticals announces registered share offering By Investing.com - Investing.com South Africa

Mar 11, 2025
pulisher
Mar 11, 2025

Salarius Pharmaceuticals announces registered share offering - Investing.com

Mar 11, 2025
pulisher
Feb 27, 2025

SLRX stock touches 52-week low at $1.22 amid market challenges - Investing.com Australia

Feb 27, 2025
pulisher
Feb 25, 2025

SLRX stock touches 52-week low at $1.22 amid market challenges By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 18, 2025

Salarius Pharmaceuticals Inc to Host Earnings Call - ACCESS Newswire

Feb 18, 2025
pulisher
Feb 11, 2025

Salarius Pharmaceuticals (NASDAQ:SLRX) Shares Up 0.5% – Still a Buy? - Defense World

Feb 11, 2025
pulisher
Feb 07, 2025

What Recent Market Trends Mean for Salarius Pharmaceuticals Inc’s (SLRX) Stock - The News Heater

Feb 07, 2025

Salarius Pharmaceuticals Inc (SLRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
大文字化:     |  ボリューム (24 時間):